Molecular modelling study of the mechanism of high-potency inhibition of human catechol-O-methyltransferase by (–)-epigallocatechin-3-O-gallate

References

• Åqvist J, Marelius J. The linear interaction energy method for predicting ligand binding free energies. Combined Chemistry High-Throughput Screening 2001; 4: 613–626
   PubMed Web of Science ®Google Scholar
• Axelrod J. Methylation reactions in the formation and metabolism of catecholamines and other biogenic amines. Pharmacology Reviews 1966; 18: 95–113
   PubMed Web of Science ®Google Scholar
• Axelrod J, Tomchick R. Enzymatic O-methylation of epinephrine and other catechols. Journal of Biology and Chemistry 1958; 233: 702–705
   PubMed Web of Science ®Google Scholar
• Bai H-W, Shim J-Y, Yu J, Zhu BT. Biochemical and molecular modeling studies of the O-methylation of various endogenous and exogenous catechol substrates catalysed by recombinant human soluble and membrane-bound catechol-O-methyltransferases. Chemical Research in Toxicology 2007; 20: 1409–1425
   PubMed Web of Science ®Google Scholar
• Ding HQ, Karasawa N, Goddard WA III. Atomic level simulations on a million particles — the cell multipole method of Coulomb and London nonbond interactions. Journal of Chemistry and Physics 1992; 97: 4309–4315
   Web of Science ®Google Scholar
• Dudev T, Lim C. Principles governing Mg, Ca, and Zn binding and selectivity in proteins. Chemistry Reviews 2003; 103: 773–787
   PubMed Web of Science ®Google Scholar
• Ghosh A, Rapp CS, Friesner RA. Generalized born model based on a surface integral formulation. Journal of Physics and Chemistry B 1998; 102: 10983–10990
   Web of Science ®Google Scholar
• Huang MT, Ho CT, Wang ZY, Ferraro T, Finnegan-Olive T, Lou YR, Mitchell JM, Laskin JD, Newmark H, Yang CS. Inhibitory effect of topical application of a green tea polyphenol fraction on tumor initiation and promotion in mouse skin. Carcinogenesis 1992; 13: 947–954
   PubMed Web of Science ®Google Scholar
• Inoue MB, Inoue M, Fernando Q, Valcic S, Timmermann BN. Potentiometric and 1H NMR studies of complexation of Al3+ with (–)-epigallocatechin gallate, a major active constituent of green tea. Journal of Inorganic Biochemistry 2002; 88: 7–13
   PubMed Web of Science ®Google Scholar
• Lee AJ, Cai MX, Thomas PE, Conney AH, Zhu BT. Characterization of the oxidative metabolites of 17β-estradiol and estrone formed by fifteen selectively-expressed human cytochrome P450 isoforms. Endocrinology 2003; 144: 3382–3398
   PubMed Web of Science ®Google Scholar
• Lu H, Meng X, Yang CS. Enzymology of methylation of tea catechins and inhibition of catechol-O-methyltransferase by (–)-epigallocatechin gallate. Drug Metabolism and Disposition 2003; 31: 572–579
   PubMed Web of Science ®Google Scholar
• Männistö PT, Kaakkola S. Catechol-O-methyltransferase (COMT): Biochemistry, molecular biology, pharmacology, and clinical efficacy of the new selective COMT inhibitors. Pharmacology Reviews 1999; 51: 593–628
   PubMed Web of Science ®Google Scholar
• Männistö PT, Ulmanen I, Lundström K, Taskinen J, Tenhunen J, Tilgmann C, Kaakkola S. Characteristics of catechol-O-methyltransferase (COMT) and properties of selective COMT inhibitors. Progress in Drug Research 1992; 39: 291–350
   PubMedGoogle Scholar
• Mooberry SL. New insights into 2-methoxyestradiol, a promising antiangiogenic and antitumor agent. Current Opinions in Oncology 2003; 15: 425–430
   PubMedGoogle Scholar
• Morrison JF. Kinetics of the reversible inhibition of enzyme-catalysed reactions by tight-binding inhibitors. Biochimica et Biophysica Acta 1969; 185: 269–286
   PubMed Web of Science ®Google Scholar
• Nagai M, Conney AH, Zhu BT. Strong inhibitory effects of common tea catechins and bioflavonoids on the O-methylation of catechol estrogens catalysed by human liver cytosolic catechol-O-methyltransferase. Drug Metabolism and Disposition 2004; 32: 497–504
   PubMed Web of Science ®Google Scholar
• Press WH, Teukolsky SA, Vetterling WT, Flannery BP. Minimization and maximization of functions. In: Numerical recipes — the art of scientific computing. Cambridge University Press, Cambridge 1992; 420–424
   Google Scholar
• Pribluda VS, Gubish ER Jr, Lavallee TM, Treston A, Swartz GM, Green SJ. 2-Methoxyestradiol: An endogenous antiangiogenic and antiproliferative drug candidate. Cancer Metastasis Reviews 2000; 19: 173–179
   PubMed Web of Science ®Google Scholar
• Saintot M, Malaveille C, Hautefeuille A, Gerber M. Interactions between genetic polymorphism of cytochrome P450-1B1, sulfotransferase 1A1, catechol-O-methyltransferase and tobacco exposure in breast cancer risk. International Journal of Cancer 2003; 107: 652–657
   PubMed Web of Science ®Google Scholar
• Shi S, Yan L, Yang Y, Fisher-Shaulsky J, Thacher T. An extensible and systematic force field, ESFF, for molecular modeling of organic, inorganic, and organometallic systems. Journal of Computing and Chemistry 2003; 24: 1059–1076
   PubMed Web of Science ®Google Scholar
• Skrzypczak-Jankun E, Zhou K, Jankun J. Inhibition of lipoxygenase by (–)-epigallocatechin gallate: X-ray analysis at 2.1 A reveals degradation of EGCG and shows soybean LOX-3 complex with EGC instead. International Journal of Molecular Medicine 2003; 12: 415–420
   PubMed Web of Science ®Google Scholar
• Vidgren J, Svensson LA, Lijas A. Crystal structure of catechol O-methyltransferase. Nature 1994; 368: 354–358
   PubMed Web of Science ®Google Scholar
• Williams JW, Morrison JF. The kinetics of reversible tight-binding inhibition. Methods in Enzymology 1979; 63: 437–467
   PubMedGoogle Scholar
• Zhu BT. Catechol-O-methyltransferase (COMT)-mediated methylation metabolism of endogenous bioactive catechols and modulation by endobiotics and xenobiotics: Importance in pathophysiology and pathogenesis. Current Drug Metabolism 2002; 3: 321–349
   PubMed Web of Science ®Google Scholar
• Zhu BT. CNS dopamine oxidation and catechol-O-methyltransferase (COMT): Importance in the etiology, pharmacotherapy, and dietary prevention of Parkinson's disease. International Journal of Molecular Medicine 2004; 13: 343–354
   PubMed Web of Science ®Google Scholar
• Zhu BT, Conney AH. Is 2-methoxyestradiol an endogenous estrogen metabolite that inhibits mammary carcinogenesis?. Cancer Research 1998; 58: 2269–2277
   PubMed Web of Science ®Google Scholar
• Zhu BT, Liehr JG. Quercetin increases the severity of estradiol-induced tumorigenesis in hamster kidney. Toxicology and Applied Pharmacology 1994; 125: 149–158
   PubMed Web of Science ®Google Scholar
• Zhu BT, Liehr JG. Inhibition of catechol O-methyltransferase-catalysed O-methylation of 2- and 4-hydroxyestradiol by quercetin: Possible role in estradiol-induced tumorigenesis. Journal of Biology and Chemistry 1996; 271: 1357–1363
   PubMed Web of Science ®Google Scholar
• Zhu BT, Patel UK, Cai MX, Conney AH. Metabolic O-methylation of tea polyphenols catalysed by human placental cytosolic catechol-O-methyltransferase. Drug Metabolism and Disposition 2000; 28: 1024–1030
   PubMed Web of Science ®Google Scholar
• Zhu BT, Taneja N, Loder DP, Balentine DA, Conney AH. Effects of tea polyphenols and flavonoids on liver microsomal glucuronidation of estradiol and estrone. Journal of Steroid Biochemistry and Molecular Biology 1998; 64: 207–215
   PubMed Web of Science ®Google Scholar